← All stocks

Bio-Techne

TECH Net selling

CIK 0000842023 #68 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$437.18K

$0.00 on a plan · $320.39K straight out of an exercise

Sold at will

$116.79K

1 of 2 sales

Net

−$437.18K

−$116.79K against sales at will

By person

15 insiders · 8 transactions

4.2×

Kim Kelderman holds only 4.2 times base salary in stock. $4.00M of shares against $936.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Kim Kelderman last reported holding, valued at $48.28, the price Common Stock was last bought or sold at on the open market here, on 8 May 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Herr Amy E.

Director

—

$437.18K (2) scheduled

−$437.18K

3,256

0.0021%

$157.20K

+75.1%

Hippel James

CFO

—

170,183

0.1087%

$8.22M

+70.3%

Kelderman Kim

Chief Executive Officer

—

82,762

0.0529%

$4.00M

+99.7%

HIGGINS JOHN L

Director

—

66,876

0.0427%

$3.23M

+43.1%

BAUMGARTNER ROBERT V

Director

—

46,503

0.0297%

$2.25M

+7.1%

Nusse Roeland

Director

—

44,559

0.0285%

$2.15M

+3.4%

Geist William

PRESIDENT, PROTEIN SCIENCES

—

24,943

0.0159%

$1.20M

+461.9%

KEEGAN JOSEPH D

Director

—

15,411

0.0098%

$744.04K

+25.2%

Seth Alpna

Director

—

15,411

0.0098%

$744.04K

+25.2%

Vessey Rupert

Director

—

10,987

0.0070%

$530.45K

+39.3%

Bohnen Shane

SVP - General Counsel

—

10,360

0.0066%

$500.18K

+516.3%

Crouse Steven C.

President - Diag & Spatial Bi

—

10,237

0.0065%

$494.24K

+73.7%

Bushman Julie L

Director

—

8,775

0.0056%

$423.66K

+54.7%

McManus Matthew

President - Diag & Spatial Bio

—

7,691

0.0049%

$371.32K

—

Klimovsky Judith V.

Director

—

3,782

0.0024%

$182.59K

+456.2%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Hippel James

29 Jul 2026

CFO

Exercised, kept

62,068

$47.60

$2.95M

Kelderman Kim

28 Jul 2026

Chief Executive Officer

Exercised, kept

35,000

$47.60

$1.67M

Bohnen Shane

23 Jul 2026

SVP - General Counsel

Exercised, kept

448

$47.60

$21.32K

Herr Amy E.

8 May 2026

Director

Sold after exercise indirect

6,636

$48.28

$320.39K

Kelderman Kim

5 May 2026

Chief Executive Officer

Exercised, kept

26,692

$47.60

$1.27M

Bohnen Shane

5 May 2026

SVP - General Counsel

Exercised, kept

8,400

$47.60

$399.84K

Hippel James

5 May 2026

CFO

Exercised, kept

62,000

$47.60

$2.95M

Herr Amy E.

17 Feb 2026

Director

Sell indirect

1,976

$59.11

$116.79K

Bio-Techne

By person

Individual transactions

What was left out